Related Experiment Videos
Aortic valve operation after percutaneous aortic balloon valvuloplasty
R G Johnson1, J S Dhillon, R L Thurer
1Section of Cardiothoracic Surgery, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts.
The Annals of Thoracic Surgery
|May 1, 1990
Summary
Percutaneous aortic balloon valvuloplasty is a palliative treatment for aortic stenosis, often requiring subsequent surgery. It offers temporary relief for high-risk patients but does not replace definitive valve replacement.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Percutaneous aortic balloon valvuloplasty (PABV) was performed in 179 patients between January 1986 and May 1988.
- A significant proportion of patients (25%) later required surgical intervention.
Purpose of the Study:
- To evaluate the outcomes and role of PABV as a palliative procedure.
- To identify patient groups most suitable for PABV.
Main Methods:
- Retrospective analysis of 179 patients who underwent PABV.
- Tracking subsequent operative interventions and patient outcomes.
Main Results:
- Forty-five patients (25%) required subsequent surgery, with indications including patient preference (15) and high operative risk (30).
- Of the 42 patients undergoing elective surgery, all experienced symptom progression and valvular restenosis.
- Despite high-risk status, mortality was low (4 hospital deaths, 3 late deaths), with improved outcomes for survivors post-operation.
Conclusions:
- PABV should be considered a palliative measure for aortic stenosis.
- It is best reserved for patients unsuitable for surgery or as a bridge to definitive treatment.